ArticleBioinformatics advances2026
Desiderata for a biomedical knowledge network: opportunities, challenges and future directions.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- How Advanced Artificial Intelligence Technologies Shape Drug-Drug and Drug-Target Interaction Modeling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Knowledge Graph-Driven AI in Biohealth: From Biomedical Discovery to Health Risk Prediction.Delaware journal of public health · 2026Article
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
Motivation: Knowledge graphs (KGs), collectively as a knowledge network, have become critical tools for knowledge discovery in computable and explainable knowledge systems. Due to the semantic and structural complexities of biomedical data, these KGs need to enable dynamic reasoning over large evolving graphs and support fit-for-purpose abstraction. Crucially, this requires establishing standards, preserving provenance and enforcing policy constraints for actionable discovery. Results: A recent meeting of leading scientists discussed the opportunities, challenges, and future directions of a biomedical knowledge network. Here we present six desiderata inspired by the meeting: (i) inference and reasoning in biomedical KGs need domain-centric approaches, (ii) harmonized and accessible standards are required for knowledge graph representation and metadata, (iii) robust validation of biomedical KGs needs multilayered, context-aware approaches that are both rigorous and scalable, (iv) the evolving and synergistic relationship between KGs and large language models is essential in empowering AI-driven biomedical discovery, (v) integrated development environments, public repositories, and governance frameworks are essential for secure and reproducible knowledge graph sharing, and (vi) robust validation, provenance, and ethical governance are critical for trustworthy biomedical KGs. Addressing these key issues will be essential to realize the promises of a biomedical knowledge network in advancing biomedicine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.